Methyl morpholine oxide → HCID 69064365, compound
Reaction equation
[CH:1]1([CH2:4][CH:5]2[CH:10]3[CH:6]2[CH2:7][CH2:8][CH:9]3[OH:11])[CH2:3][CH2:2]1.C[N+]1([O-])CCOCC1>C(Cl)Cl.CCC[N+](CCC)(CCC)CCC.[O-][Ru](=O)(=O)=O>[CH:1]1([CH2:4][CH:5]2[CH:10]3[CH:6]2[CH2:7][CH2:8][C:9]3=[O:11])[CH2:2][CH2:3]1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of 6-cyclopropylmethyl-bicyclo[3.1.0]hexan-2-ol (220 mg, 1.45 mmol) in 10 mL DCM was added sequentially 4 A Molecular sieves (200 mg), NMO (N-Methyl morpholine N-oxide) (339 mg, 2.90 mmol), TPAP label (25.448 mg, 0.0725 mmol). The mixture was stirred overnight at room temperature and plugged through silica gel (3:1 DCM: Et2O) to give 6-cyclopropylmethyl-bicyclo[3.1.0]hexan-2-one as a clear oil; 1H NMR (400 MHz, CDCl3): δ 2.32–2.21 (m, 2H), 2.16 (dd, 1H, J1=13.4 Hz, J2=5.4 Hz), 1.97–1.86 (m, 3H), 1.61–1.53 (m, 1H), 1.38–1.28 (m, 2H), 0.82–0.73 (m, 1H), 0.49–0.44 (m, 2H), 0.09–0.05 (m, 2H).
Sources & evidence
- ORD record
- ord-7414d95263ca455baa25b5242f670880
- Source dataset
- uspto-grants-2007_07
- Patent number
- US07241792B2
Reaction notes
Loading…